Analytical post exploring CAR-T cell therapy’s potential to treat Alzheimer’s by targeting amyloid plaques, with insights from recent clinical trials and cost-benefit considerations. Innov...
Recent studies reveal CAR-T cells with lecanemab antibodies reduce amyloid plaques in mice, highlighting a shift towards personalized cell-based therapies for Alzheimer’s treatment. New research...
